Skip To Main Content
Jan Harald Aarseth on Muck Rack

Jan Harald Aarseth

As seen in: Journal of Neurology, Neurosurgery and Psychiatry, SAGE Publishing, Neurology, Multiple Sclerosis and Related Disorders
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jan Harald

Contact Jan Harald, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Between-hospital variation in discontinuation of treatment with dimethyl fumarate in multiple sclerosis

|
By Hilde Norborg, Stephan Bramow, Jan Harald Aarseth
| Multiple Sclerosis and Related Disorders Verified
Keywords Dimethyl Fumarate Multiple Sclerosis Duration of Treatment Registries Hospital Medicine Get full text access Log in, subscribe or purchase for full access. References 1. Menzin, J. ∙ Caon, C. ∙ Nichols, C. ... Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis J Manag Care Pharm. 2013; 19:S24-S40 2013/02/13 2. Jongen, P.J. ∙ Lemmens, W.A. ∙ Hupperts, R. ...
Open in Who Shared Issue with article?

Effect of early highly effective treatment compared to an escalating treatment strategy in multiple sclerosis

|
By Jan Harald Aarseth, Nina Grytten, Hilde Norborg
| Multiple Sclerosis and Related Disorders Verified
Keywords MS highly effective treatment strategies DMT real-world escalating survival analyses Get full text access Log in, subscribe or purchase for full access. REFERENCES 1. 1 Filippi, M. ∙ Amato, M.P. ∙ Centonze, D. ... Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion Journal of neurology. Oct 2022; 269:5382-5394 2. 2 Torkildsen, Ø ∙ Myhr, K.M. ∙ Bø, L.
Open in Who Shared Issue with article?

BCG vaccination and multiple sclerosis risk: A Norwegian cohort study

|
By Jan Harald Aarseth, Stig Wergeland, Hein Stigum, Ola Nakken
| SAGE Publishing
Introduction A relationship between vaccinations and the risk of developing multiple sclerosis (MS) has not been firmly established.1,2 Conclusions from meta-analyses are difficult as the vast majority of studies on this topic have been retrospective case–control studies, which are prone to biases.
Open in Who Shared Issue with article?
See all 9 articles